Bio/Pharmaceutical GMP Product Testing - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Bio/Pharmaceutical GMP Product Testing

Eurofins BioPharma Product Testing is the largest network of harmonized bio/pharmaceutical GMP product testing laboratories worldwide providing comprehensive laboratory services for the world’s largest pharmaceutical, biopharmaceutical and medical device companies.

Our service offerings are fully comprehensive and include testing of drug substance, final product, intermediates, and starting materials for both small and large molecule drug products.

With a global capacity of more than 500,000 square feet and facilities located in Belgium, Denmark, France, Germany, Ireland, Italy, Spain, Sweden and the U.S., our network of GMP laboratories operates under the same strict quality procedures, LIMS and centralized billing system across 14 locations worldwide.

We give our clients the flexibility to choose from five service models to meet specific project needs, including the award-winning Professional Scientific StaffingSM (PSS) and we also provide secure 24-hour data access via our online data portal, LabAccess.com SM.

Company name:  Eurofins Scientific

Website: www.Eurofins.com/Biopharma

E-mail: Pharma@Eurofins.com
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
11%
Protecting the supply chain
37%
Expedited reviews of drug submissions
11%
More stakeholder involvement
11%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
FindPharma Custom Search

Click here